Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion‐body myopathy muscle
- 25 December 2007
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 105 (3) , 971-981
Abstract
Autosomal recessive hereditary inclusion‐body myopathy (h‐IBM) is caused by mutations of the UDP‐N‐acetylglucosamine 2‐epimerase/N‐acetylmannosamine kinase gene, a rate‐limiting enzyme in the sialic acid metabolic pathway. Previous studies have demonstrated an abnormal sialylation of glycoproteins in h‐IBM. h‐IBM muscle shows the abnormal accumulation of proteins including amyloid‐β (Aβ). Neprilysin (NEP), a metallopeptidase that cleaves Aβ, is characterized by the presence of several N‐glycosylation sites, and changes in these sugar moieties affect its stability and enzymatic activity. In the present study, we found that NEP is hyposialylated and its expression and enzymatic activity reduced in all h‐IBM muscles analyzed. In vitro, the experimental removal of sialic acid by Vibrio Cholerae neuraminidase in cultured myotubes resulted in reduced expression of NEP. This was most likely because of a post‐translational modification consisting in an abnormal sialylation of the protein that leads to its reduced stability. Moreover, treatment with Vibrio Cholerae neuraminidase was associated with an increased immunoreactivity for Aβ mainly in the form of distinct cytoplasmic foci within myotubes. We hypothesize that, in h‐IBM muscle, hyposialylated NEP has a role in hampering the cellular Aβ clearing system, thus contributing to its abnormal accumulation within vulnerable fibers and possibly promoting muscle degeneration.Keywords
This publication has 36 references indexed in Scilit:
- Characterization of hereditary inclusion body myopathy myoblasts: possible primary impairment of apoptotic eventsCell Death & Differentiation, 2007
- Enhanced sialylation of EPO by overexpression of UDP‐GlcNAc 2‐epimerase/ManAc kinase containing a sialuria mutation in CHO cellsFEBS Letters, 2007
- Loss of Neprilysin Function Promotes Amyloid Plaque Formation and Causes Cerebral Amyloid AngiopathyThe American Journal of Pathology, 2007
- A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathyHuman Molecular Genetics, 2007
- No overall hyposialylation in hereditary inclusion body myopathy myoblasts carrying the homozygous M712T GNE mutationBiochemical and Biophysical Research Communications, 2005
- Enhanced Proteolysis of β-Amyloid in APP Transgenic Mice Prevents Plaque Formation, Secondary Pathology, and Premature DeathNeuron, 2003
- Neprilysin Degrades Both Amyloid β Peptides 1–40 and 1–42 Most Rapidly and Efficiently among Thiorphan- and Phosphoramidon-sensitive EndopeptidasesJournal of Biological Chemistry, 2001
- Metabolic Regulation of Brain Aβ by NeprilysinScience, 2001
- Neutral endopeptidase can hydrolyze β-amyloid(1–40) but shows no effect on β-amyloid precursor protein metabolismPeptides, 1995
- Enzymes in placental microvilli: Angiotensin I converting enzyme, angiotensinase A, carboxypeptidase, and neutral endopeptidase (“enkephalinase”)Peptides, 1984